Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant

NCT00089453 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Dexamethasone
DRUG: Cyclophosphamide
DRUG: Melphalan
DRUG: Fludarabine
DRUG: Bortezomide
PROCEDURE: Leukapheresis
DRUG: Interleukin
PROCEDURE: Infusion #1
PROCEDURE: Leukapheresis #2
PROCEDURE: Infusion #2
PROCEDURE: Auto Graft

Sponsor

University of Arkansas